Cargando…

Procalcitonin is a good marker for the diagnosis of infection and the severity of illness in patients with SIRS

Detalles Bibliográficos
Autores principales:	Endo, S, Kasai, T, Koike, S, Yamada, Y, Inoue, Y, Taniguchi, S, Inada, K, Ikeda, K, Ikeda, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1999
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301794/ http://dx.doi.org/10.1186/cc466

Ejemplares similares

Does transforming growth factor-β inhibit nitric oxide synthesis and prevent septic shock?
por: Endo , S, et al.
Publicado: (1999)

Plasma nuclear matrix protein (NMP) levels in patients with multiple organ failure
por: Endo, S, et al.
Publicado: (1997)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome
por: Endo, S, et al.
Publicado: (1998)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Adhesion molecule, soluble adhesion molecule, and cytokine levels in patients with severe burns
por: Endo, S, et al.
Publicado: (1998)

Interleukin-18 levels reflect the severity of acute pancreatitis
por: Abe, H, et al.
Publicado: (2003)

Procalcitonin (PCT) for monitoring ICU patients with severe polytrauma and early SIRS: results of a prospective study
por: Stiletto, RJ, et al.
Publicado: (1998)

Tumor necrosis factor receptor I, II and tumor necrosis factor-α levels in patients with burns
por: Endo, S, et al.
Publicado: (2000)

Autoantibodies against oxidated low density lipoproteins (oLAb) and procalcitonin (PCT) as prognostic markers for patients suffering from sepsis and systemic inflammatory response syndrome (SIRS)
por: Reiger, J, et al.
Publicado: (1998)

Procalcitonin level as a marker of severe sepsis and septic shock patients who required polymyxin-B immobilized fiber with direct hemoperfusion
por: Ikeda, T, et al.
Publicado: (2012)

Treatment of postoperative lung injury in patients with SIRS by methylprednisolone
por: Sumida, M, et al.
Publicado: (1998)

Effect of continuous hemodiafiltration (CHDF) on vascular endothelial cell function in sepsis patients
por: Ikeda, K, et al.
Publicado: (2003)

Is procalcitonin a new surrogate marker for hypoxic brain damage?
por: Fries, M, et al.
Publicado: (2002)

Changes in procalcitonin in septic shock patients treated with endotoxin adsorption therapy
por: Ikeda, T, et al.
Publicado: (2005)

Procalcitonin is released by human monocytes
por: Russwurm, S, et al.
Publicado: (1999)

Endotoxin adsorption method may affect serum procalcitonin
por: Ikeda, T, et al.
Publicado: (2008)

Good Bye ‘Sir’
por: Kumar, Rakesh
Publicado: (2013)

Procalcitonin: a prognostic marker for critically ill
por: Bhattacharyya, M, et al.
Publicado: (2009)

Changes in the C-type Natriuretic peptide (CNP) and NO derivatives in the plasma and CSF of the patients with subarachnoid hemorrhage (SAH)
por: Ikeda, K, et al.
Publicado: (2000)

Influence of extracorporeal circulation on the kinetics of procalcitonin
por: Kiessling, A-H, et al.
Publicado: (1999)

Differential diagnosis of Th1/Th2-response by T-cell and monocyte function between sepsis and non-infectious SIRS via flowcytometry
por: Imamura, Y, et al.
Publicado: (2001)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

Procalcitonin, a marker of systemic inflammation response to peritonitis which contribute to therapies strategy
por: Lepousé, C, et al.
Publicado: (2001)

Serum procalcitonin levels in bacterial and viral meningitis
por: Schwarz , S, et al.
Publicado: (1999)

1334. Performance of C-Reactive Protein and Procalcitonin in Immunocompromised Children with SIRS
por: Posch, Leila C, et al.
Publicado: (2019)

Procalcitonin as a marker of infection in critically ill patients
por: Koukiasa, P, et al.
Publicado: (2004)

Expression and regulation of procalcitonin in different human cells
por: Ruβwurm, S, et al.
Publicado: (2000)

Procalcitonin in autoimmune disease with sepsis
por: Leonhardt, U, et al.
Publicado: (2001)

Changes in complement cascade during continuous hemodiafiltration (CHDF) in patients with sepsis
por: Ikeda, K, et al.
Publicado: (2002)

Endotoxin and cytokines in patients with gastrointestinal tract perforation
por: Endo, S., et al.
Publicado: (1992)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Downregulation of procalcitonin in mechanicaly ventilated patients
por: Gleiβ, J, et al.
Publicado: (1999)

Correlation between changes in mediators and number of dysfunctional organs in sepsis-associated multiple organ dysfunction syndrome (MODS)
por: Taniuchi, H, et al.
Publicado: (2003)

Postoperative plasma concentrations of procalcitonin after different types of surgery
por: Meisner, M, et al.
Publicado: (1998)

Secretory phospholipase A2 (sPLA2), procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis and differentiation of septic shock and non-septic shock
por: Anglès, O, et al.
Publicado: (2000)

The change of procalcitonin concentrations after tracheostomy at bedside
por: Sato, K, et al.
Publicado: (2015)

Procalcitonin in the critically ill
por: Kazda, A, et al.
Publicado: (2005)

Selenium substitution in patients with severe systemic inflammatory response syndrome (SIRS)
por: Angstwurm, MWA, et al.
Publicado: (1998)

Is it true that PMX-DHP can improve lung oxygenation?
por: Ikeda, T, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_vvs709ucm216sci71s3805cqip